[go: up one dir, main page]
More Web Proxy on the site http://driver.im/ Skip to main content

Advertisement

Springer Nature Link
Log in

The management of osteoporosis in hospitalized patients with fragility hip fractures in western Saudi Arabia: a real-world tertiary center experience

  • Original Article
  • Published:
Archives of Osteoporosis Aims and scope Submit manuscript

Abstract

Summary

Osteoporotic fractures, especially fragility hip fractures, are major causes of mortality and morbidity in the elderly. There is a significant gap in the diagnosis and treatment of osteoporosis in patients with fragility fractures. Vitamin D use increased by 18.2% post-admission, while calcium use rose by 21.1%. Additionally, the prescription of bisphosphonates, an osteoclast inhibitor, increased by 1.2% post-admission. The study highlights the urgent need for improved management practices and more proactive care strategies to address osteoporosis and its complications.

Introduction

Osteoporotic fractures are a major cause of fragility hip fractures, and in Saudi Arabia, the high prevalence of osteoporosis and high costs highlight the need for comprehensive care. This study aimed to evaluate the management of osteoporosis in hospitalized patients with fragility hip fractures in western Saudi Arabia.

Methods

This retrospective cohort study examined medical records from individuals with fragility hip fractures at King Abdulaziz Medical City in Saudi Arabia, Jeddah, from 2004 to 2024. Data was collected from electronic health records, including demographics, clinical features, comorbidities, fall history, osteoporosis diagnosis, and medication usage.

Results

The study included 314 patients, with a mean age of 73 years and 31.2% being between 71 and 80 years old. The majority were females, with a mean BMI of 26.6 kg/m2. The most common comorbidity was renal failure. The prevalence of pre-admission diagnosis of osteoporosis was 14%. Post-admission DEXA-BMD use was reported by 16.6%. Vitamin D (41.1%) and calcium (42.4%) were higher in post-admission management compared to pre-admission management.

Conclusion

The study found that most hospitalized patients with fragility hip fractures were female, overweight, had a history of falls, and suffered from renal failure. This study opens new areas for future research that could increase our understanding of osteoporosis management.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Subscribe and save

Springer+ Basic
£29.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or eBook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Price includes VAT (United Kingdom)

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

Data Availability

Primary data available upon reasonable request.

References

  1. Bukata SV, Digiovanni BF, Friedman SM et al (2011) A guide to improving the care of patients with fragility fractures. Geriatr Orthop Surg Rehabil 2:5–37. https://doi.org/10.1177/2151458510397504

    Article  PubMed  PubMed Central  Google Scholar 

  2. Bentler SE, Liu L, Obrizan M et al (2009) The aftermath of hip fracture: discharge placement, functional status change, and mortality. Am J Epidemiol 170:1290–1299. https://doi.org/10.1093/aje/kwp266

    Article  PubMed  PubMed Central  Google Scholar 

  3. Lee GE, Muffly S, Golladay GJ (2019) Management of fragility hip fractures: our institutional experience. Geriatr Orthop Surg Rehabil 10:2151459319828618. https://doi.org/10.1177/2151459319828618

    Article  PubMed  PubMed Central  Google Scholar 

  4. Ip TP, Leung J, Kung AWC (2010) Management of osteoporosis in patients hospitalized for hip fractures. Osteoporos Int 21:S605-614. https://doi.org/10.1007/s00198-010-1398-8

    Article  CAS  PubMed  Google Scholar 

  5. Hodsman AB, Leslie WD, Tsang JF, Gamble GD (2008) 10-year probability of recurrent fractures following wrist and other osteoporotic fractures in a large clinical cohort: an analysis from the Manitoba Bone Density Program. Arch Intern Med 168:2261. https://doi.org/10.1001/archinte.168.20.2261

    Article  PubMed  Google Scholar 

  6. Satomi E (2009) Sitta M do C, Machado AN, Garcez Leme LE: Identification and treatment of osteoporosis among elderly patients with hip fractures. Clinics (Sao Paulo) 64:1201–1204. https://doi.org/10.1590/S1807-59322009001200010

    Article  PubMed  Google Scholar 

  7. Panneman MJM, Lips P, Sen SS, Herings RMC (2004) Undertreatment with anti-osteoporotic drugs after hospitalization for fracture. Osteoporos Int 15:120–124. https://doi.org/10.1007/s00198-003-1544-7

    Article  PubMed  Google Scholar 

  8. Tai T-W, Li C-C, Huang C-F, Chan WP, Wu C-H (2022) Treatment of osteoporosis after hip fracture is associated with lower all-cause mortality: a nationwide population study. Bone 154:116216. https://doi.org/10.1016/j.bone.2021.116216

    Article  CAS  PubMed  Google Scholar 

  9. Rabenda V, Vanoverloop J, Fabri V et al (2008) Low incidence of anti-osteoporosis treatment after hip fracture. J Bone Joint Surg-Am Vol 90:2142–2148. https://doi.org/10.2106/JBJS.G.00864

    Article  Google Scholar 

  10. Beaupre LA, Majumdar SR, Dieleman S, Au A, Morrish DW (2012) Diagnosis and treatment of osteoporosis before and after admission to long-term care institutions. Osteoporos Int 23:573–580. https://doi.org/10.1007/s00198-011-1582-5

    Article  CAS  PubMed  Google Scholar 

  11. Kung AW, Fan T, Xu L et al (2013) Factors influencing diagnosis and treatment of osteoporosis after a fragility fracture among postmenopausal women in Asian countries: a retrospective study. BMC Women’s Health 13:7. https://doi.org/10.1186/1472-6874-13-7

    Article  PubMed  PubMed Central  Google Scholar 

  12. El-Desouki MI (2003) Osteoporosis in postmenopausal Saudi women using dual x-ray bone densitometry. Saudi Med J 24:953–956

    PubMed  Google Scholar 

  13. Sadat-Ali M, Al-Habdan IM, Al-Turki HA, Azam MQ (2012) An epidemiological analysis of the incidence of osteoporosis and osteoporosis-related fractures among the Saudi Arabian population. Ann Saudi Med 32:637–641. https://doi.org/10.5144/0256-4947.2012.637

    Article  PubMed  PubMed Central  Google Scholar 

  14. Amin TT, Al Owaifeer A, Al-Hashim H, AlWosaifer A, Alabdulqader M, Al Hulaibi F, Al Hamam A (2013) Osteoporosis among older Saudis: risk of fractures and unmet needs. Arch Osteoporos 8:118. https://doi.org/10.1007/s11657-013-0118-3

    Article  PubMed  Google Scholar 

  15. Bubshait D, Sadat-Ali M (2007) Economic implications of osteoporosis-related femoral fractures in Saudi Arabian Society. Calcif Tissue Int 81:455–458. https://doi.org/10.1007/s00223-007-9090-5

    Article  CAS  PubMed  Google Scholar 

  16. Sadat-Ali M, Al-Omran A, Al-Bakr W, Azam MQ, Tantawy A, Al-Othman A (2014) Established osteoporosis and gaps in the management: review from a teaching hospital. Ann Med Health Sci Res 4:198–201. https://doi.org/10.4103/2141-9248.129038

    Article  PubMed  PubMed Central  Google Scholar 

  17. Al Saleh Y, El Seid ME, Ruhaiyem ME et al (2020) Characteristics and outcomes of osteoporotic hip fractures: treatment gaps in a tertiary care center in Riyadh. Saudi Arabia Aging Clin Exp Res 32:1689–1695. https://doi.org/10.1007/s40520-019-01377-2

    Article  PubMed  Google Scholar 

  18. Imran M, Singh A, Bhardwaj A, Agrawal D (2022) Prevalence of osteoporosis and associated risk factors among postmenopausal women: a cross-sectional study from northern India. J Midlife Health 13:206–212. https://doi.org/10.4103/jmh.jmh_114_22

    Article  PubMed  Google Scholar 

  19. Puth M-T, Klaschik M, Schmid M, Weckbecker K, Münster E (2018) Prevalence and comorbidity of osteoporosis– a cross-sectional analysis on 10,660 adults aged 50 years and older in Germany. BMC Musculoskelet Disord 19:144. https://doi.org/10.1186/s12891-018-2060-4

    Article  PubMed  PubMed Central  Google Scholar 

  20. Sözen T, Özışık L, Başaran NÇ (2017) An overview and management of osteoporosis. Eur J Rheumatol 4:46–56. https://doi.org/10.5152/eurjrheum.2016.048

    Article  PubMed  Google Scholar 

  21. Samson Enitan S, Ngozi Adejumo E, Osaigbovoh Imaralu J, Ademola Adelakun A, Anike Ladipo O, Bosede Enitan C (2023) Personalized medicine approach to osteoporosis management in women: integrating genetics, pharmacogenomics, and precision treatments. Clin Res Commun. 6:18. https://doi.org/10.53388/CRC2023018

    Article  Google Scholar 

  22. Asadipooya K, Abdalbary M, Ahmad Y, Kakani E, Monier-Faugere M-C, El-Husseini A (2021) Bone quality in chronic kidney disease patients: current concepts and future directions - part II. Kidney Dis (Basel) 7:359–371. https://doi.org/10.1159/000515542

    Article  PubMed  Google Scholar 

  23. Huang J-F, Zheng X-Q, Sun X-L et al (2020) Association between bone mineral density and severity of chronic kidney disease. Int J Endocrinol 2020:1–11. https://doi.org/10.1155/2020/8852690

    Article  CAS  Google Scholar 

  24. Resnick B, Nahm ES, Zhu S, Brown C, An M, Park B, Brown J (2014) The impact of osteoporosis, falls, fear of falling, and efficacy expectations on exercise among community-dwelling older adults. Orthop Nurs 33:277–86; quiz 287–8. https://doi.org/10.1097/NOR.0000000000000084

  25. Morrison A, Fan T, Sen SS, Weisenfluh L (2013) Epidemiology of falls and osteoporotic fractures: a systematic review. Clinicoecon Outcomes Res 5:9–18. https://doi.org/10.2147/CEOR.S38721

    Article  PubMed  Google Scholar 

  26. Afrin N, Sund R, Honkanen R, Koivumaa-Honkanen H, Rikkonen T, Williams L, Kröger H (2020) A fall in the previous 12 months predicts fracture in the subsequent 5 years in postmenopausal women. Osteoporos Int 31:839–847. https://doi.org/10.1007/s00198-019-05255-5

    Article  CAS  PubMed  Google Scholar 

  27. Han A, Park Y, Lee Y-K, Park SY, Park CY (2022) Position statement: vitamin D intake to prevent osteoporosis and fracture in adults. J Bone Metab. 29:205–15. https://doi.org/10.11005/jbm.2022.29.4.205

    Article  PubMed  PubMed Central  Google Scholar 

  28. Lewiecki EM (2000) Osteoporosis: Clinical Evaluation. In: Feingold KR, Anawalt B, Blackman MR, et al. (eds) Endotext. MDText.com, Inc, South Dartmouth (MA)

  29. Bodenner D, Redman C, Riggs A (2007) Teriparatide in the management of osteoporosis. Clin Interv Aging 2:499–507. https://doi.org/10.2147/cia.s241

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  30. Roy AN, Mazumdar I (2023) Effects of teriparatide treatment on bone mineral density in patients with osteoporosis: a short-term dose-response study. Cureus 15:e45662. https://doi.org/10.7759/cureus.45662

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Acknowledgements

The authors gratefully acknowledge Content Concepts (www.contentconcepts.com) for the English language editing.

Author information

Authors and Affiliations

  1. Department of Medicine, King Abdulaziz Medical City, Jeddah, Saudi Arabia

    Fayez S. Alharthy, Abdullah Almalki, Saeed S. Majadah & Salwa B. Alaidarous

  2. College of Medicine, King Saud Bin Abdulaziz University for Health Sciences, Jeddah, Saudi Arabia

    Fayez S. Alharthy, Renad F. Alharthy & Salwa B. Alaidarous

  3. King Abdullah International Medical Research Center, Jeddah, Saudi Arabia

    Fayez S. Alharthy, Abdullah Almalki, Renad F. Alharthy & Salwa B. Alaidarous

  4. King Fahad Hospital, Jeddah, Saudi Arabia

    Eman A. Alsindi

  5. Prince Mohammad Bin Abdulaziz Hospital, Almadinah, Saudi Arabia

    Sahar S. Alahmadi

Authors
  1. Fayez S. Alharthy
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Abdullah Almalki
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Eman A. Alsindi
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Saeed S. Majadah
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Sahar S. Alahmadi
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Renad F. Alharthy
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Salwa B. Alaidarous
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

All authors contributed to the study conception and design. Material preparation, data collection, and analysis were performed by Fayez S. Alharthy, Saeed S. Majadah, Salwa B. Alaidarous, and Eman A. Alsindi. The first draft of the manuscript was written by Sahar S. Alahmadi, Renad F. Alharthy, and Abdullah Almalki. All authors read and approved the final manuscript.

Corresponding author

Correspondence to Fayez S. Alharthy.

Ethics declarations

Conflicts of interest

None.

Disclaimer

The views expressed in the submitted article are not an official position of the institution and only the authors’ opinion.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Alharthy, F.S., Almalki, A., Alsindi, E.A. et al. The management of osteoporosis in hospitalized patients with fragility hip fractures in western Saudi Arabia: a real-world tertiary center experience. Arch Osteoporos 20, 29 (2025). https://doi.org/10.1007/s11657-025-01511-w

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1007/s11657-025-01511-w

Keywords

Search

Navigation